UMS increases lithotripsy business

USMD Health Systems has sold US Lithotripsy LP to United Medical Systems, Inc. (UMS), a subsidiary of private investment firm New State Capital Partners. UMS provides turnkey mobile lithotripsy, laser and stereotactic breast biopsy services to patients at 850 healthcare facilities in the U.S., Canada and Latin America. The acquired company, US Lithotripsy, is a […]

Agenus on a roll in 2015

Agenus Inc., an immunology company developing novel checkpoint modulators, vaccines and adjuvants to treat cancer, acquired Phoslmmune Inc. last week. Phoslmmune is an immunotherapy company that has discovered a new portfolio of cancer neoantigens. Its equity holders will receive an upfront payment of $2.5 million in cash and $7.4 million in shares of Agenus common […]

Hospital M&A in 2015

It’s been a busy year for mergers and acquisitions in the Hospital sector, and it’s not over yet. Our preliminary figures show 101 transactions with a combined deal value of $8.7 billion. At least two announced transactions have been terminated, and there are still a few to track down, so those numbers will change. Of […]

Shryver Medical and Revelstoke Capital Double Down in Texas

Schryver Medical LLC, a portfolio company of Revelstoke Capital Partners, announced two acquisitions in Texas in late December. Community Portable X-Ray, Inc., as its name implies, provides mobile x-ray and other imaging services to long-term health care facilities, home care, psychiatric hospitals, industrial sites, dialysis centers and athletic teams. Besides its base in Plano, it also […]

WellSpan Ups Its Behavioral Health Offerings

The Behavioral Health Care sector has seen plenty of mergers and acquisitions this year. Deal volume is currently up 38% (33 deals) compared with 2014’s full-year total of 24 transactions. With six deals announced in December, the sector will close out the year on a high note. One deal has been in the works almost […]

Martin Shkreli, We Hardly Knew Ye

Actually, we know Martin Shkreli, CEO of KaloBios Pharmaceuticals (NASDAQ: KBIO), all too well. The brash young man was arrested by the Federal Bureau of Investigations yesterday in Manhattan, on charges of fraud relating to his days at a hedge. Just weeks before, as then-CEO of privately held Turing Pharmaceuticals, he became the poster child […]